Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
The restoration of DPNH oxidase activity by coenzyme Q (ubiquinone)
1966 • 160 citations
Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells
1974 • 154 citations
Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity
1974 • 153 citations
Effects of seven anthracyclin antibiotics on electrocardiogram and mitochondrial function of rat hearts
1975 • 73 citations
Deficiency of coenzyme Q 10 in human heart disease. II.
1972 • 59 citations
The inhibition of NADH oxidase by the lower homologs of coenzyme Q
1975 • 44 citations
The potential of coenzyme Q 10 (NSC-140865) in cancer treatment.
1974 • 23 citations
Experimental adriamycin cardiotoxicity prevented by ubiquinone in vivo in rabbits
1975 • 16 citations
Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
1975 • 15 citations
Study of periodontal disease and coenzyme Q.
1975 • 13 citations
Coenzyme Q. 167. Antimetabolites of coenzyme Q. 19. Synthesis and bioassays of new dimethoxyalkylmercapto-1,4-benzoquinones
1974 • 12 citations
Antimetabolites of coenzyme Q. XV. Inhibition of mitochondrial reductase systems by naphthoquinone and quinolinequinone analogs.
1973 • 6 citations
Apparent low levels of ubiquinone in rat and human neoplastic tissues.
1968 • 6 citations
The Integration of Adriamycin into Combined Therapy Approaches
1975 • 4 citations